查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999360

体外震波碎石术市场：依技术、应用、最终用户、便携性和治疗模式划分－2026-2032年全球市场预测

Extracorporeal Shock Wave Lithotripsy Market by Technology, Application, End User, Portability, Treatment Mode - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，体外震波碎石术 (ESWL) 市值将达到 3.8292 亿美元，到 2026 年将成长至 4.1024 亿美元，到 2032 年将达到 6.0268 亿美元，年复合成长率为 6.69%。

主要市场统计数据
基准年 2025 3.8292亿美元
预计年份：2026年 4.1024亿美元
预测年份 2032 6.0268亿美元
复合年增长率 (%) 6.69%

策略实施概述，概述了影响现代体外震波碎石术 (ESWL) 采用的临床效用、工作流程影响和决策标准。

体外震波碎石术（ESWL）作为一种非侵入性治疗方法，在现代泌尿系统中发挥核心作用，用于击碎胆管和泌尿道结石。其临床意义在于，它能够利用聚焦声能击碎结石，同时最大限度地减少手术创伤，从而加快患者康復并有效利用医疗资源。近年来，随着影像技术、衝击波发生技术以及设备人体工学改进的进步，ESWL已从一种纯粹的院内手术发展成为一种高度灵活的治疗选择，广泛应用于门诊手术中心和诊所。

技术进步、分散式治疗模式与临床路径优化如何影响体外震波碎石术的现况？

体外震波碎石术（ESWL）领域正经历一场变革，其驱动力来自技术、临床和操作等多面向因素的共同作用。衝击波发生技术的创新，例如电解法、电磁法和压电法，正在优化能量传递和设备耐用性；而整合成像和即时回馈技术的进步则提高了靶点定位精度和临床疗效。同时，设备便携性的提升模糊了固定式医院系统和适用于门诊环境的行动治疗单元之间的界限，催生了新的医疗服务模式，并扩大了社区医疗中心的覆盖范围。

新关税趋势对体外震波碎石术 (ESWL) 生态系统的供应链策略、采购惯例和总成本的影响。

2025年关税的实施为医疗设备生态系统带来了新的挑战，包括供应链韧性、筹资策略和产品定价等问题。体外震波碎石术（ESWL）相关人员正透过营运和商业手段相结合的方式来应对这些压力。面对进口零件成本的增加，製造商探索了多种方案，例如关键子组件的垂直整合、策略性库存以及製造地的地域多元化，以降低风险。同时，服务提供者也审查了备件库存和维护合同，以确保运作，同时避免将过高的成本转嫁给临床客户。

详细的細項分析揭示了技术类型、临床应用、使用者环境、便携性和治疗模式如何决定产品定位和部署路径。

细分市场分析突显了技术选择、临床应用、使用者环境、便携性要求和治疗模式等方面的关键差异，这些差异共同影响着产品设计和市场进入策略。电液、电磁和压电系统之间的技术选择不仅影响聚焦精度和能量分散等临床性能特征，还影响可维护性、运行噪音和资本投资趋势。这些差异指南医院系统、门诊手术中心和诊所在决策过程中，根据手术量和医疗目标来选择合适的设备功能。

区域监管差异、医疗基础设施成熟度和服务网路如何影响体外震波碎石术 (ESWL) 技术的部署策略？

区域趋势受制于不同的法规环境、医疗基础设施和支付体系，这些因素影响技术的采取路径和竞争策略。在美洲，先进临床中心的集中分布和广泛的门诊手术中心网络催生了对兼具性能和可维护性的设备的需求。同时，报销政策和资本投资週期影响技术的采用时机。清晰的监管政策和成熟的技术服务生态系统为下一代系统的应用提供了支持，医疗服务提供者也日益寻求能够简化患者诊疗流程和文件记录的整合解决方案。

竞争和服务生态系统分析表明，设备差异化、临床伙伴关係和售后服务如何决定市场定位和采购结果。

体外震波碎石术（ESWL）产业格局复杂，老字型大小企业，也有创新新晋参与企业和专业服务供应商，各方都在临床疗效、设备可靠性和售后服务方面展开竞争。主要製造商持续致力于透过改进衝击波发生技术和整合成像功能来实现产品差异化，同时增加对培训和技术支援的投入，以减轻临床团队的营运负担。新晋参与企业和小型供应商则专注于细分市场，例如可携式系统和针对门诊及诊所环境优化的高性价比机型，并力求透过极具吸引力的整体价值提案来改变现有的采购模式。

为製造商和供应商提供切实可行的优先建议，以调整产品设计、服务模式和证据生成，从而满足多样化的临床和区域需求。

产业领导企业应采取多管齐下的策略，将技术开发、经营模式和临床医生协作相结合，以掌握体外震波碎石术 (ESWL) 领域的新机会。首先，应优先考虑设备的模组化和互通性，以便在不更换整个系统的情况下，透过不断升级来适应不断发展的成像和目标撷取功能。这可以减少医院和诊所客户在整个生命週期中的中断，并促进长期合作关係。其次，应设计能反映终端使用者多样性的定价和服务方案，包括门诊手术中心、多专科诊所、泌尿系统诊所以及公立和私立医院。具体而言，可以透过提供扩充性的合约来实现这一点，这些合约既适用于独立式和医院安装的门诊设备，也适用于固定式高通量系统。

我们采用透明的混合方法研究途径，结合临床文献、监管分析、技术审查和相关人员访谈，得出基于证据的策略见解。

本分析的研究结合了近期同行评审的临床文献、监管文件和产品技术文檔，并结合对临床专家、采购经理和医疗设备工程师的结构化访谈。调查方法强调三角验证，将领域专家的定性见解与设备规格和服务记录进行交叉比对，以检验对技术性能、维护概况和临床工作流程的解读准确可靠。此外，还检视了区域监管指南和公共报销框架，以明确市场准入考量因素并识别实际应用障碍。

简要概述了技术进步、营运重点和当地情况与扩大体外震波碎石术应用范围的策略挑战之间的连结。

总之，体外震波碎石术（ESWL）仍然是非侵入性碎石治疗中一项至关重要的技术，其未来发展方向将受到技术进步、分散式医疗模式和切实可行的商业策略的影响。电液、电磁和压电系统的进步，以及影像整合和便携性的提升，正在拓展安全有效实施ESWL的可能性。同时，门诊流程设计、可维护性和供应链韧性等营运需求正在影响采购决策，并塑造竞争优势。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：体外震波碎石术市场：依技术划分

  • 电液式
  • 电磁
  • 压电

第九章：体外震波碎石市场：依应用领域划分

  • 胆结石
  • 肾结石
  • 输尿管结石

第十章：体外震波碎石市场：依最终用户划分

  • 门诊手术中心
    • 独立设施
    • 医院设施
  • 诊所
    • 全科诊所
    • 泌尿系统诊所
  • 医院
    • 私立医院
    • 公立医院

第十一章 体外震波碎石市场：便携式

  • 移动的
  • 固定式

第十二章 体外震波碎石术市场依治疗方法划分

  • 住院治疗
  • 门诊

第十三章 体外震波碎石市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 体外震波碎石市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 体外震波碎石术市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国体外震波碎石市场

第十七章：中国体外震波碎石市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Beijing Well Medical Technology Co., Ltd.
  • Chongqing Haifu Ultrasound Technology Co., Ltd.
  • Dornier MedTech GmbH
  • EDAP TMS SA
  • EMS Electro Medical Systems SA
  • Medstone International Urology Pvt. Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • Storz Medical AG
Product Code: MRR-3A2E844FE771

The Extracorporeal Shock Wave Lithotripsy Market was valued at USD 382.92 million in 2025 and is projected to grow to USD 410.24 million in 2026, with a CAGR of 6.69%, reaching USD 602.68 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 382.92 million
Estimated Year [2026] USD 410.24 million
Forecast Year [2032] USD 602.68 million
CAGR (%) 6.69%

A strategic introductory overview that frames clinical utility, workflow implications, and decision criteria shaping contemporary extracorporeal shock wave lithotripsy adoption

Extracorporeal shock wave lithotripsy (ESWL) occupies a central role in contemporary urological care as a noninvasive modality for fragmenting calculi across the biliary and urinary tracts. Its clinical relevance is rooted in the ability to deliver focused acoustic energy to disrupt stones while minimizing surgical trauma, enabling faster recovery and reduced hospital resource utilization. Over recent years, ESWL has evolved from a purely hospital-based intervention to a versatile therapeutic option used across ambulatory surgical centers and clinics, supported by improvements in imaging, shock wave generation, and device ergonomics.

Clinicians and administrators alike are evaluating ESWL not only through clinical efficacy but also through workflow integration, patient throughput, and reimbursement dynamics. Technological refinements have improved stone localization and energy delivery, and these enhancements have accelerated adoption in settings beyond traditional inpatient units. Consequently, strategic decision-makers are balancing clinical outcomes, capital allocation, and operational considerations as they determine the role of ESWL within urology service lines.

This introduction establishes the clinical and operational context for stakeholders assessing the ESWL landscape. It lays the groundwork for sections that follow, which examine transformational shifts, tariff implications, segmentation insights, regional dynamics, competitive positioning, and practical recommendations for industry leaders seeking to position products and services for sustainable growth and clinical impact.

How converging technological refinements, decentralized delivery models, and clinical pathway optimization are reshaping the extracorporeal shock wave lithotripsy landscape

The ESWL landscape is undergoing transformative shifts driven by converging technological, clinical, and operational forces. Innovations in shock wave generation-spanning electrohydraulic, electromagnetic, and piezoelectric approaches-are optimizing energy delivery and device longevity, while advances in integrated imaging and real-time feedback are improving targeting accuracy and clinical outcomes. Parallel developments in portability have blurred the lines between stationary, hospital-based systems and mobile units suited to ambulatory environments, thereby enabling new care delivery models and extending access to community-based centers.

Clinical pathways are also evolving, with greater emphasis on outpatient treatment models and protocols that reduce inpatient burden. Ambulatory surgical centers, including both freestanding and hospital-based centers, are increasingly positioned to deliver ESWL safely and efficiently, and multispecialty clinics as well as urology-focused clinics are exploring service expansions. These shifts are accompanied by refinements in perioperative care and patient selection that enhance patient satisfaction and lower overall system costs.

Concurrently, regulatory scrutiny and device lifecycle management are prompting manufacturers to prioritize safety features, ease of use, and serviceability. Outcomes data and real-world evidence are being deployed to differentiate product value propositions, while collaborative models between clinicians, device makers, and payers are emerging to address reimbursement and access barriers. Taken together, these trends signal a transition toward more patient-centric, decentralized, and technology-driven ESWL care paradigms.

Impacts of new tariff dynamics on supply chain strategies, procurement practices, and total cost considerations within the extracorporeal shock wave lithotripsy ecosystem

The imposition of tariffs in 2025 introduced new considerations for supply chain resiliency, procurement strategy, and product pricing within the medical device ecosystem, and ESWL stakeholders are navigating these pressures with a mix of operational and commercial responses. Manufacturers faced with increased costs for imported components evaluated options including vertical integration of key subassemblies, strategic stockpiling, and selective geographic diversification of manufacturing footprints to mitigate exposure. In parallel, service organizations reexamined spare parts inventories and maintenance contracts to sustain uptime without passing disproportionate cost burdens to clinical customers.

Healthcare providers and purchasing groups reacted by intensifying scrutiny on total cost of ownership, prioritizing devices that offered longer service intervals, local technical support, and parts commonality across installed bases. As a result, procurement negotiations began to emphasize bundled service arrangements and outcome-based warranties that align maintenance incentives with device performance. For some market participants, tariffs accelerated conversations about nearshoring and partnerships with regional suppliers to stabilize supply chains and reduce lead times.

Importantly, these adaptations were complemented by increased investment in logistics visibility and risk modeling tools, which helped organizations anticipate disruptions and plan mitigations. While tariffs altered cost equations and contractual structures, they also prompted practical innovations in manufacturing strategy and supplier collaboration that can enhance long-term reliability and responsiveness across the ESWL value chain.

Detailed segmentation insights revealing how technology type, clinical application, user environment, portability, and treatment mode define product positioning and adoption pathways

Segment analysis highlights meaningful distinctions in technology preferences, clinical applications, user settings, portability requirements, and treatment modes that collectively shape product design and go-to-market strategies. Technology choice between electrohydraulic, electromagnetic, and piezoelectric systems influences not only clinical performance characteristics such as focal precision and energy dispersion but also serviceability, operating noise, and capital expenditure profiles. These differences guide decisions by hospital systems, ambulatory surgical centers, and clinics when aligning device capabilities with procedural volumes and care objectives.

Application segmentation between gallbladder stones, renal calculi, and ureteral calculi underscores divergent clinical requirements related to stone composition, size distribution, and anatomical access. Devices optimized for renal calculi may prioritize deeper focal penetration and adjustable energy profiles, while systems used for ureteral fragments require rapid targeting and integration with auxiliary imaging modalities. End-user diversity is significant: ambulatory surgical centers, both freestanding and hospital-based, emphasize throughput and rapid turnover; clinics, including multispecialty and urology clinics, prioritize ease of use and space efficiency; and hospitals, whether private or public, demand robust service support and regulatory compliance. Portability preferences split between mobile units that enable outreach and stationary systems that anchor high-volume centers, affecting installation requirements and marketing narratives.

Treatment mode considerations-namely inpatient versus outpatient pathways-further influence device feature sets, service contracts, and reimbursement interactions. Outpatient procedures prioritize streamlined patient flow and minimal anesthesia requirements, while inpatient settings focus on comprehensive perioperative integration and complex case capabilities. Taken together, these segmentation insights provide a nuanced framework for product positioning and commercial prioritization across stakeholder cohorts.

How regional regulatory variability, care infrastructure maturity, and service networks drive differentiated adoption strategies for extracorporeal shock wave lithotripsy technologies

Regional dynamics are shaped by diverse regulatory environments, care delivery infrastructures, and payer systems that affect adoption pathways and competitive strategies. In the Americas, a concentration of advanced clinical centers and extensive ambulatory surgical networks creates demand for devices that balance performance with serviceability, while reimbursement policies and capital procurement cycles influence adoption timing. Regulatory clarity and established technical service ecosystems support the introduction of next-generation systems, and providers increasingly seek integrated solutions that streamline patient throughput and documentation.

Across Europe, the Middle East & Africa, the landscape is heterogeneous: mature Western European systems emphasize evidence-based adoption and budgetary accountability, while emerging markets in the region prioritize cost-effective technologies and scalable service models. Regulatory frameworks vary, and market entrants benefit from localized clinical partnerships and adaptable commercial models that reflect payer diversity. In the Asia-Pacific region, rapid expansion of ambulatory capacity, investments in healthcare infrastructure, and growing clinical expertise are driving demand for both stationary high-throughput systems and mobile units that serve geographically dispersed populations. Local manufacturing partnerships and responsive after-sales networks play an outsized role in accelerating adoption and building clinician confidence.

Understanding these regional nuances is essential for companies seeking to tailor regulatory strategies, pricing approaches, and distribution models that align with local healthcare delivery and reimbursement realities. Transitioning from regional analysis to tactical planning, stakeholders should prioritize regulatory alignment, service network development, and clinician engagement to capture opportunities across varied markets.

Competitive and service ecosystem analysis showing how device differentiation, clinical partnerships, and after-sales support determine market positioning and procurement outcomes

Competitive dynamics in the ESWL sector reflect a mix of legacy incumbents, innovative entrants, and specialized service providers, each competing on clinical performance, device reliability, and after-sales support. Leading manufacturers maintain emphasis on product differentiation through advances in shock wave generation and imaging integration, while simultaneously investing in training and technical support that reduce operational friction for clinical teams. New entrants and smaller suppliers focus on niche opportunities, such as portable systems or cost-effective models tailored to ambulatory and clinic settings, seeking to disrupt established purchasing patterns with compelling total-value propositions.

Service organizations and third-party maintenance providers play a strategic role, particularly in regions where local technical capacity is limited. Partnerships between manufacturers and regional distributors are instrumental for scaling access and ensuring rapid parts availability, which in turn affects hospital and clinic preferences. Strategic collaborations between device makers and clinical champions are also shaping product roadmaps, with real-world evidence and clinician feedback driving iterative improvements in user interfaces, targeting accuracy, and patient comfort.

From a commercial perspective, differentiation increasingly hinges on demonstrable outcomes, ease of integration into existing workflows, and predictable lifecycle costs. Companies that can combine robust clinical evidence, responsive service networks, and adaptable financing or procurement models are best positioned to win procurement discussions and to expand installed bases across diverse care settings.

Practical and prioritized recommendations for manufacturers and providers to align product design, service models, and evidence generation with varied clinical and regional demands

Industry leaders should adopt a multi-pronged approach that aligns technology development, commercial models, and clinician engagement to capture emerging opportunities in ESWL. First, prioritize device modularity and interoperability so that systems can be upgraded with evolving imaging and targeting capabilities without requiring full replacement; this reduces total lifecycle disruption for hospital and clinic customers and supports long-term relationships. Second, design pricing and service bundles that reflect the diversity of end users-ambulatory surgical centers, multispecialty clinics, urology clinics, and both private and public hospitals-by offering scalable contracts that accommodate freestanding and hospital-based ambulatory units as well as stationary high-throughput systems.

Third, invest in regional service infrastructure and partnerships to shorten response times for maintenance and spare parts, which is particularly important in markets where local technical capacity is variable. Fourth, generate and disseminate robust real-world evidence across applications such as gallbladder stones, renal calculi, and ureteral calculi to support clinician adoption and reimbursement dialogues. Fifth, evaluate supply chain resilience measures-such as diversified sourcing and nearshoring-that mitigate tariff and logistics risks while maintaining quality standards. By sequencing these initiatives and aligning them with targeted regional strategies, companies can build durable competitive advantage and foster clinician trust.

Finally, foster clinician training programs and collaborative pilots that demonstrate operational efficiencies and patient outcomes; these initiatives not only accelerate adoption but also create advocates who help navigate institutional procurement processes and payer negotiations.

Transparent mixed-methods research approach combining clinical literature, regulatory analysis, technical review, and stakeholder interviews to produce evidence-based strategic insights

Research for this analysis combined a review of recent peer-reviewed clinical literature, regulatory filings, product technical documentation, and structured interviews with clinical specialists, procurement executives, and device engineers. The methodology emphasized triangulation: qualitative insights from domain experts were cross-validated with device specifications and service records to ensure robust interpretation of technology performance, maintenance profiles, and clinical workflows. Additionally, regional regulatory guidance and public reimbursement frameworks were examined to inform market access considerations and to identify practical barriers to adoption.

Primary research included discussions with clinicians across care settings-hospital inpatient units, ambulatory surgical centers both freestanding and hospital-based, multispecialty clinics, and specialized urology clinics-to capture diverse perspectives on device usability, patient selection, and integration into care pathways. Technical assessments considered differences across electrohydraulic, electromagnetic, and piezoelectric systems, as well as portability characteristics between mobile and stationary platforms. Supply chain and procurement perspectives were incorporated to reflect tariff impacts and logistics considerations.

Findings were synthesized into thematic insights that inform segmentation, regional dynamics, competitive positioning, and actionable recommendations. Throughout the research process, care was taken to separate clinical evidence from commercial assertions and to document assumptions underlying strategic implications.

Concise concluding synthesis linking technological evolution, operational priorities, and regional realities to the strategic imperatives for expanding extracorporeal shock wave lithotripsy access

In conclusion, extracorporeal shock wave lithotripsy remains a pivotal technology for noninvasive stone management, and its future trajectory will be shaped by technology refinement, decentralized care models, and pragmatic commercial strategies. Advances across electrohydraulic, electromagnetic, and piezoelectric systems, together with improvements in imaging integration and portability, are expanding the contexts in which ESWL can be delivered safely and effectively. Meanwhile, operational imperatives-such as outpatient pathway design, serviceability, and supply chain resilience-are influencing procurement decisions and shaping competitive differentiation.

Regional nuances underscore the importance of tailored approaches that reflect regulatory environments, payer structures, and local technical capabilities across the Americas, Europe Middle East & Africa, and Asia-Pacific markets. Competitive advantage will accrue to organizations that combine demonstrable clinical outcomes with reliable service networks and flexible commercial models that address the needs of ambulatory surgical centers, clinics, and hospitals. By translating clinical efficacy into predictable operational performance and manageable lifecycle costs, stakeholders can support broader access to ESWL while aligning product and service strategies with healthcare system priorities.

Ultimately, the path forward involves coordinated investments in technology, evidence generation, and regional partnerships that together enable scalable, patient-centered lithotripsy services across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal Shock Wave Lithotripsy Market, by Technology

  • 8.1. Electrohydraulic
  • 8.2. Electromagnetic
  • 8.3. Piezoelectric

9. Extracorporeal Shock Wave Lithotripsy Market, by Application

  • 9.1. Gallbladder Stones
  • 9.2. Renal Calculi
  • 9.3. Ureteral Calculi

10. Extracorporeal Shock Wave Lithotripsy Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Freestanding Centers
    • 10.1.2. Hospital Based Centers
  • 10.2. Clinics
    • 10.2.1. Multispecialty Clinics
    • 10.2.2. Urology Clinics
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals

11. Extracorporeal Shock Wave Lithotripsy Market, by Portability

  • 11.1. Mobile
  • 11.2. Stationary

12. Extracorporeal Shock Wave Lithotripsy Market, by Treatment Mode

  • 12.1. Inpatient
  • 12.2. Outpatient

13. Extracorporeal Shock Wave Lithotripsy Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal Shock Wave Lithotripsy Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal Shock Wave Lithotripsy Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Extracorporeal Shock Wave Lithotripsy Market

17. China Extracorporeal Shock Wave Lithotripsy Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Beijing Well Medical Technology Co., Ltd.
  • 18.6. Chongqing Haifu Ultrasound Technology Co., Ltd.
  • 18.7. Dornier MedTech GmbH
  • 18.8. EDAP TMS SA
  • 18.9. EMS Electro Medical Systems SA
  • 18.10. Medstone International Urology Pvt. Ltd.
  • 18.11. Olympus Corporation
  • 18.12. Richard Wolf GmbH
  • 18.13. Siemens Healthineers AG
  • 18.14. Storz Medical AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 155. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 156. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 157. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 158. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 177. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 183. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 184. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 185. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 191. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 192. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 194. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)